nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Quinine—CYP3A4—bone cancer	0.00932	0.439	CrCbGaD
Quinidine barbiturate—Quinidine—CYP3A4—bone cancer	0.00819	0.386	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP3A4—bone cancer	0.00371	0.175	CrCbGaD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—FLI1—bone cancer	0.00319	0.107	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—T—bone cancer	0.00295	0.0991	CbGpPWpGaD
Quinidine barbiturate—Thrombocytopenia—Cisplatin—bone cancer	0.00203	0.00213	CcSEcCtD
Quinidine barbiturate—Tachycardia—Cisplatin—bone cancer	0.00202	0.00213	CcSEcCtD
Quinidine barbiturate—Skin disorder—Cisplatin—bone cancer	0.00201	0.00212	CcSEcCtD
Quinidine barbiturate—Diplopia—Doxorubicin—bone cancer	0.002	0.00211	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Cisplatin—bone cancer	0.002	0.00211	CcSEcCtD
Quinidine barbiturate—Asthma—Methotrexate—bone cancer	0.002	0.0021	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Epirubicin—bone cancer	0.002	0.0021	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Epirubicin—bone cancer	0.00197	0.00208	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Epirubicin—bone cancer	0.00197	0.00208	CcSEcCtD
Quinidine barbiturate—Anorexia—Cisplatin—bone cancer	0.00197	0.00208	CcSEcCtD
Quinidine barbiturate—Affect lability—Doxorubicin—bone cancer	0.00197	0.00207	CcSEcCtD
Quinidine barbiturate—Breast disorder—Epirubicin—bone cancer	0.00195	0.00206	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00195	0.00205	CcSEcCtD
Quinidine barbiturate—Hypotension—Cisplatin—bone cancer	0.00193	0.00204	CcSEcCtD
Quinidine barbiturate—GRIA2—Hypothetical Network for Drug Addiction—GRM1—bone cancer	0.00193	0.0648	CbGpPWpGaD
Quinidine barbiturate—Muscular weakness—Epirubicin—bone cancer	0.00191	0.00201	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Doxorubicin—bone cancer	0.0019	0.002	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Methotrexate—bone cancer	0.0019	0.002	CcSEcCtD
Quinidine barbiturate—Mood swings—Doxorubicin—bone cancer	0.00189	0.002	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00188	0.00199	CcSEcCtD
Quinidine barbiturate—Ataxia—Doxorubicin—bone cancer	0.00188	0.00198	CcSEcCtD
Quinidine barbiturate—Asthma—Epirubicin—bone cancer	0.00187	0.00197	CcSEcCtD
Quinidine barbiturate—Neutropenia—Methotrexate—bone cancer	0.00187	0.00197	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Doxorubicin—bone cancer	0.00185	0.00195	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Cisplatin—bone cancer	0.00184	0.00194	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Doxorubicin—bone cancer	0.00183	0.00192	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Doxorubicin—bone cancer	0.00183	0.00192	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Methotrexate—bone cancer	0.00182	0.00192	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Epirubicin—bone cancer	0.00182	0.00192	CcSEcCtD
Quinidine barbiturate—Breast disorder—Doxorubicin—bone cancer	0.00181	0.0019	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.0018	0.0019	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Cisplatin—bone cancer	0.0018	0.00189	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Cisplatin—bone cancer	0.00179	0.00188	CcSEcCtD
Quinidine barbiturate—Drowsiness—Methotrexate—bone cancer	0.00178	0.00188	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Epirubicin—bone cancer	0.00177	0.00187	CcSEcCtD
Quinidine barbiturate—Pain—Cisplatin—bone cancer	0.00177	0.00186	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00176	0.00186	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Doxorubicin—bone cancer	0.00176	0.00186	CcSEcCtD
Quinidine barbiturate—Renal failure—Methotrexate—bone cancer	0.00175	0.00184	CcSEcCtD
Quinidine barbiturate—Neutropenia—Epirubicin—bone cancer	0.00175	0.00184	CcSEcCtD
Quinidine barbiturate—Asthma—Doxorubicin—bone cancer	0.00173	0.00182	CcSEcCtD
Quinidine barbiturate—Sweating—Methotrexate—bone cancer	0.00171	0.0018	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Epirubicin—bone cancer	0.00171	0.0018	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Cisplatin—bone cancer	0.0017	0.0018	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Doxorubicin—bone cancer	0.00168	0.00177	CcSEcCtD
Quinidine barbiturate—Drowsiness—Epirubicin—bone cancer	0.00167	0.00175	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Methotrexate—bone cancer	0.00166	0.00175	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00165	0.00174	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Doxorubicin—bone cancer	0.00164	0.00173	CcSEcCtD
Quinidine barbiturate—Renal failure—Epirubicin—bone cancer	0.00164	0.00173	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Cisplatin—bone cancer	0.00164	0.00172	CcSEcCtD
Quinidine barbiturate—Jaundice—Epirubicin—bone cancer	0.00162	0.00171	CcSEcCtD
Quinidine barbiturate—Neutropenia—Doxorubicin—bone cancer	0.00162	0.0017	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Methotrexate—bone cancer	0.00161	0.00169	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Methotrexate—bone cancer	0.0016	0.00168	CcSEcCtD
Quinidine barbiturate—Hepatitis—Methotrexate—bone cancer	0.0016	0.00168	CcSEcCtD
Quinidine barbiturate—Sweating—Epirubicin—bone cancer	0.0016	0.00168	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Methotrexate—bone cancer	0.00158	0.00166	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Doxorubicin—bone cancer	0.00158	0.00166	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Methotrexate—bone cancer	0.00157	0.00165	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Epirubicin—bone cancer	0.00155	0.00164	CcSEcCtD
Quinidine barbiturate—Drowsiness—Doxorubicin—bone cancer	0.00154	0.00162	CcSEcCtD
Quinidine barbiturate—Visual impairment—Methotrexate—bone cancer	0.00154	0.00162	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00153	0.00161	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Cisplatin—bone cancer	0.00152	0.00161	CcSEcCtD
Quinidine barbiturate—Bradycardia—Epirubicin—bone cancer	0.00152	0.0016	CcSEcCtD
Quinidine barbiturate—Renal failure—Doxorubicin—bone cancer	0.00151	0.0016	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Methotrexate—bone cancer	0.00151	0.00159	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Epirubicin—bone cancer	0.0015	0.00158	CcSEcCtD
Quinidine barbiturate—Jaundice—Doxorubicin—bone cancer	0.0015	0.00158	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Epirubicin—bone cancer	0.0015	0.00158	CcSEcCtD
Quinidine barbiturate—Hepatitis—Epirubicin—bone cancer	0.0015	0.00158	CcSEcCtD
Quinidine barbiturate—Eye disorder—Methotrexate—bone cancer	0.00149	0.00157	CcSEcCtD
Quinidine barbiturate—Tinnitus—Methotrexate—bone cancer	0.00149	0.00157	CcSEcCtD
Quinidine barbiturate—Asthenia—Cisplatin—bone cancer	0.00148	0.00156	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Methotrexate—bone cancer	0.00148	0.00156	CcSEcCtD
Quinidine barbiturate—Sweating—Doxorubicin—bone cancer	0.00148	0.00156	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Epirubicin—bone cancer	0.00148	0.00156	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Epirubicin—bone cancer	0.00147	0.00154	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—FEV—bone cancer	0.00146	0.0491	CbGpPWpGaD
Quinidine barbiturate—Immune system disorder—Methotrexate—bone cancer	0.00144	0.00152	CcSEcCtD
Quinidine barbiturate—Visual impairment—Epirubicin—bone cancer	0.00144	0.00152	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Methotrexate—bone cancer	0.00144	0.00152	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Doxorubicin—bone cancer	0.00144	0.00152	CcSEcCtD
Quinidine barbiturate—Chills—Methotrexate—bone cancer	0.00143	0.00151	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—FEV—bone cancer	0.00142	0.0476	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Cisplatin—bone cancer	0.00142	0.00149	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Epirubicin—bone cancer	0.00141	0.00149	CcSEcCtD
Quinidine barbiturate—Bradycardia—Doxorubicin—bone cancer	0.00141	0.00148	CcSEcCtD
Quinidine barbiturate—Mental disorder—Methotrexate—bone cancer	0.0014	0.00147	CcSEcCtD
Quinidine barbiturate—Eye disorder—Epirubicin—bone cancer	0.0014	0.00147	CcSEcCtD
Quinidine barbiturate—Tinnitus—Epirubicin—bone cancer	0.00139	0.00147	CcSEcCtD
Quinidine barbiturate—Malnutrition—Methotrexate—bone cancer	0.00139	0.00147	CcSEcCtD
Quinidine barbiturate—Erythema—Methotrexate—bone cancer	0.00139	0.00147	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Doxorubicin—bone cancer	0.00139	0.00147	CcSEcCtD
Quinidine barbiturate—Flushing—Epirubicin—bone cancer	0.00139	0.00146	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Epirubicin—bone cancer	0.00139	0.00146	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Doxorubicin—bone cancer	0.00138	0.00146	CcSEcCtD
Quinidine barbiturate—Hepatitis—Doxorubicin—bone cancer	0.00138	0.00146	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Doxorubicin—bone cancer	0.00137	0.00144	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Doxorubicin—bone cancer	0.00136	0.00143	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Epirubicin—bone cancer	0.00135	0.00142	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Epirubicin—bone cancer	0.00135	0.00142	CcSEcCtD
Quinidine barbiturate—Chills—Epirubicin—bone cancer	0.00134	0.00141	CcSEcCtD
Quinidine barbiturate—Visual impairment—Doxorubicin—bone cancer	0.00133	0.0014	CcSEcCtD
Quinidine barbiturate—Vomiting—Cisplatin—bone cancer	0.00132	0.00139	CcSEcCtD
Quinidine barbiturate—Vision blurred—Methotrexate—bone cancer	0.00131	0.00138	CcSEcCtD
Quinidine barbiturate—Mental disorder—Epirubicin—bone cancer	0.00131	0.00138	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Doxorubicin—bone cancer	0.00131	0.00138	CcSEcCtD
Quinidine barbiturate—Rash—Cisplatin—bone cancer	0.0013	0.00137	CcSEcCtD
Quinidine barbiturate—Dermatitis—Cisplatin—bone cancer	0.0013	0.00137	CcSEcCtD
Quinidine barbiturate—Malnutrition—Epirubicin—bone cancer	0.0013	0.00137	CcSEcCtD
Quinidine barbiturate—Erythema—Epirubicin—bone cancer	0.0013	0.00137	CcSEcCtD
Quinidine barbiturate—Eye disorder—Doxorubicin—bone cancer	0.00129	0.00136	CcSEcCtD
Quinidine barbiturate—Tinnitus—Doxorubicin—bone cancer	0.00129	0.00136	CcSEcCtD
Quinidine barbiturate—Flushing—Doxorubicin—bone cancer	0.00128	0.00135	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Doxorubicin—bone cancer	0.00128	0.00135	CcSEcCtD
Quinidine barbiturate—Tension—Epirubicin—bone cancer	0.00128	0.00135	CcSEcCtD
Quinidine barbiturate—Nervousness—Epirubicin—bone cancer	0.00126	0.00133	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Doxorubicin—bone cancer	0.00125	0.00132	CcSEcCtD
Quinidine barbiturate—Vertigo—Methotrexate—bone cancer	0.00125	0.00132	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Doxorubicin—bone cancer	0.00125	0.00131	CcSEcCtD
Quinidine barbiturate—Leukopenia—Methotrexate—bone cancer	0.00124	0.00131	CcSEcCtD
Quinidine barbiturate—Chills—Doxorubicin—bone cancer	0.00124	0.00131	CcSEcCtD
Quinidine barbiturate—Nausea—Cisplatin—bone cancer	0.00123	0.00129	CcSEcCtD
Quinidine barbiturate—Vision blurred—Epirubicin—bone cancer	0.00123	0.00129	CcSEcCtD
Quinidine barbiturate—Mental disorder—Doxorubicin—bone cancer	0.00121	0.00128	CcSEcCtD
Quinidine barbiturate—Convulsion—Methotrexate—bone cancer	0.00121	0.00127	CcSEcCtD
Quinidine barbiturate—Malnutrition—Doxorubicin—bone cancer	0.0012	0.00127	CcSEcCtD
Quinidine barbiturate—Erythema—Doxorubicin—bone cancer	0.0012	0.00127	CcSEcCtD
Quinidine barbiturate—Agitation—Epirubicin—bone cancer	0.0012	0.00126	CcSEcCtD
Quinidine barbiturate—Myalgia—Methotrexate—bone cancer	0.00118	0.00125	CcSEcCtD
Quinidine barbiturate—Chest pain—Methotrexate—bone cancer	0.00118	0.00125	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methotrexate—bone cancer	0.00118	0.00125	CcSEcCtD
Quinidine barbiturate—Tension—Doxorubicin—bone cancer	0.00118	0.00125	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00118	0.00124	CcSEcCtD
Quinidine barbiturate—Nervousness—Doxorubicin—bone cancer	0.00117	0.00123	CcSEcCtD
Quinidine barbiturate—Vertigo—Epirubicin—bone cancer	0.00117	0.00123	CcSEcCtD
Quinidine barbiturate—Syncope—Epirubicin—bone cancer	0.00117	0.00123	CcSEcCtD
Quinidine barbiturate—Leukopenia—Epirubicin—bone cancer	0.00117	0.00123	CcSEcCtD
Quinidine barbiturate—Palpitations—Epirubicin—bone cancer	0.00115	0.00121	CcSEcCtD
Quinidine barbiturate—Confusional state—Methotrexate—bone cancer	0.00114	0.00121	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Epirubicin—bone cancer	0.00114	0.00121	CcSEcCtD
Quinidine barbiturate—Vision blurred—Doxorubicin—bone cancer	0.00113	0.0012	CcSEcCtD
Quinidine barbiturate—Convulsion—Epirubicin—bone cancer	0.00113	0.00119	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methotrexate—bone cancer	0.00111	0.00117	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Methotrexate—bone cancer	0.00111	0.00117	CcSEcCtD
Quinidine barbiturate—Arthralgia—Epirubicin—bone cancer	0.00111	0.00117	CcSEcCtD
Quinidine barbiturate—Myalgia—Epirubicin—bone cancer	0.00111	0.00117	CcSEcCtD
Quinidine barbiturate—Chest pain—Epirubicin—bone cancer	0.00111	0.00117	CcSEcCtD
Quinidine barbiturate—Agitation—Doxorubicin—bone cancer	0.00111	0.00117	CcSEcCtD
Quinidine barbiturate—Anxiety—Epirubicin—bone cancer	0.0011	0.00116	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methotrexate—bone cancer	0.0011	0.00116	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.0011	0.00116	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methotrexate—bone cancer	0.0011	0.00116	CcSEcCtD
Quinidine barbiturate—Vertigo—Doxorubicin—bone cancer	0.00108	0.00114	CcSEcCtD
Quinidine barbiturate—Anorexia—Methotrexate—bone cancer	0.00108	0.00114	CcSEcCtD
Quinidine barbiturate—Syncope—Doxorubicin—bone cancer	0.00108	0.00114	CcSEcCtD
Quinidine barbiturate—Leukopenia—Doxorubicin—bone cancer	0.00108	0.00114	CcSEcCtD
Quinidine barbiturate—Confusional state—Epirubicin—bone cancer	0.00107	0.00113	CcSEcCtD
Quinidine barbiturate—Palpitations—Doxorubicin—bone cancer	0.00106	0.00112	CcSEcCtD
Quinidine barbiturate—Oedema—Epirubicin—bone cancer	0.00106	0.00112	CcSEcCtD
Quinidine barbiturate—Hypotension—Methotrexate—bone cancer	0.00106	0.00112	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Doxorubicin—bone cancer	0.00106	0.00112	CcSEcCtD
Quinidine barbiturate—Shock—Epirubicin—bone cancer	0.00105	0.0011	CcSEcCtD
Quinidine barbiturate—Convulsion—Doxorubicin—bone cancer	0.00104	0.0011	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Epirubicin—bone cancer	0.00104	0.0011	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Epirubicin—bone cancer	0.00104	0.0011	CcSEcCtD
Quinidine barbiturate—Tachycardia—Epirubicin—bone cancer	0.00104	0.00109	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00103	0.00109	CcSEcCtD
Quinidine barbiturate—Skin disorder—Epirubicin—bone cancer	0.00103	0.00109	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Epirubicin—bone cancer	0.00103	0.00108	CcSEcCtD
Quinidine barbiturate—Chest pain—Doxorubicin—bone cancer	0.00103	0.00108	CcSEcCtD
Quinidine barbiturate—Myalgia—Doxorubicin—bone cancer	0.00103	0.00108	CcSEcCtD
Quinidine barbiturate—Arthralgia—Doxorubicin—bone cancer	0.00103	0.00108	CcSEcCtD
Quinidine barbiturate—Anxiety—Doxorubicin—bone cancer	0.00102	0.00108	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00102	0.00107	CcSEcCtD
Quinidine barbiturate—Anorexia—Epirubicin—bone cancer	0.00101	0.00107	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Methotrexate—bone cancer	0.00101	0.00107	CcSEcCtD
Quinidine barbiturate—Somnolence—Methotrexate—bone cancer	0.00101	0.00106	CcSEcCtD
Quinidine barbiturate—Hypotension—Epirubicin—bone cancer	0.000993	0.00105	CcSEcCtD
Quinidine barbiturate—Confusional state—Doxorubicin—bone cancer	0.000991	0.00104	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Methotrexate—bone cancer	0.000987	0.00104	CcSEcCtD
Quinidine barbiturate—Oedema—Doxorubicin—bone cancer	0.000983	0.00104	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Methotrexate—bone cancer	0.00098	0.00103	CcSEcCtD
Quinidine barbiturate—Pain—Methotrexate—bone cancer	0.000971	0.00102	CcSEcCtD
Quinidine barbiturate—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000969	0.0326	CbGpPWpGaD
Quinidine barbiturate—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000968	0.00102	CcSEcCtD
Quinidine barbiturate—Shock—Doxorubicin—bone cancer	0.000967	0.00102	CcSEcCtD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000965	0.0324	CbGpPWpGaD
Quinidine barbiturate—Nervous system disorder—Doxorubicin—bone cancer	0.000964	0.00102	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.000963	0.0324	CbGpPWpGaD
Quinidine barbiturate—Thrombocytopenia—Doxorubicin—bone cancer	0.000962	0.00101	CcSEcCtD
Quinidine barbiturate—Tachycardia—Doxorubicin—bone cancer	0.000959	0.00101	CcSEcCtD
Quinidine barbiturate—Skin disorder—Doxorubicin—bone cancer	0.000955	0.00101	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Doxorubicin—bone cancer	0.00095	0.001	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Epirubicin—bone cancer	0.000947	0.000998	CcSEcCtD
Quinidine barbiturate—Somnolence—Epirubicin—bone cancer	0.000944	0.000995	CcSEcCtD
Quinidine barbiturate—Anorexia—Doxorubicin—bone cancer	0.000937	0.000987	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methotrexate—bone cancer	0.000935	0.000986	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methotrexate—bone cancer	0.000928	0.000978	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Epirubicin—bone cancer	0.000923	0.000973	CcSEcCtD
Quinidine barbiturate—Hypotension—Doxorubicin—bone cancer	0.000918	0.000968	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Epirubicin—bone cancer	0.000917	0.000966	CcSEcCtD
Quinidine barbiturate—Pain—Epirubicin—bone cancer	0.000908	0.000957	CcSEcCtD
Quinidine barbiturate—Constipation—Epirubicin—bone cancer	0.000908	0.000957	CcSEcCtD
Quinidine barbiturate—Urticaria—Methotrexate—bone cancer	0.000902	0.00095	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methotrexate—bone cancer	0.000897	0.000946	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Methotrexate—bone cancer	0.000897	0.000946	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000895	0.000944	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Doxorubicin—bone cancer	0.000876	0.000923	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Epirubicin—bone cancer	0.000875	0.000922	CcSEcCtD
Quinidine barbiturate—Somnolence—Doxorubicin—bone cancer	0.000874	0.000921	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Epirubicin—bone cancer	0.000869	0.000915	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Doxorubicin—bone cancer	0.000854	0.0009	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000849	0.000894	CcSEcCtD
Quinidine barbiturate—Urticaria—Epirubicin—bone cancer	0.000844	0.000889	CcSEcCtD
Quinidine barbiturate—Pain—Doxorubicin—bone cancer	0.000841	0.000886	CcSEcCtD
Quinidine barbiturate—Constipation—Doxorubicin—bone cancer	0.000841	0.000886	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Epirubicin—bone cancer	0.00084	0.000885	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Epirubicin—bone cancer	0.00084	0.000885	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Methotrexate—bone cancer	0.000836	0.000881	CcSEcCtD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—IL3—bone cancer	0.000832	0.028	CbGpPWpGaD
Quinidine barbiturate—Asthenia—Methotrexate—bone cancer	0.000814	0.000858	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Doxorubicin—bone cancer	0.00081	0.000853	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Doxorubicin—bone cancer	0.000804	0.000847	CcSEcCtD
Quinidine barbiturate—Pruritus—Methotrexate—bone cancer	0.000803	0.000846	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Epirubicin—bone cancer	0.000783	0.000825	CcSEcCtD
Quinidine barbiturate—Urticaria—Doxorubicin—bone cancer	0.000781	0.000823	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Doxorubicin—bone cancer	0.000777	0.000819	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Doxorubicin—bone cancer	0.000777	0.000819	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Methotrexate—bone cancer	0.000777	0.000818	CcSEcCtD
Quinidine barbiturate—Asthenia—Epirubicin—bone cancer	0.000762	0.000803	CcSEcCtD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—FEV—bone cancer	0.000754	0.0253	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Epirubicin—bone cancer	0.000752	0.000792	CcSEcCtD
Quinidine barbiturate—Dizziness—Methotrexate—bone cancer	0.000751	0.000791	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Epirubicin—bone cancer	0.000727	0.000766	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Doxorubicin—bone cancer	0.000724	0.000763	CcSEcCtD
Quinidine barbiturate—Vomiting—Methotrexate—bone cancer	0.000722	0.00076	CcSEcCtD
Quinidine barbiturate—Rash—Methotrexate—bone cancer	0.000716	0.000754	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methotrexate—bone cancer	0.000715	0.000753	CcSEcCtD
Quinidine barbiturate—Headache—Methotrexate—bone cancer	0.000711	0.000749	CcSEcCtD
Quinidine barbiturate—Asthenia—Doxorubicin—bone cancer	0.000705	0.000743	CcSEcCtD
Quinidine barbiturate—Dizziness—Epirubicin—bone cancer	0.000702	0.00074	CcSEcCtD
Quinidine barbiturate—Pruritus—Doxorubicin—bone cancer	0.000695	0.000733	CcSEcCtD
Quinidine barbiturate—Vomiting—Epirubicin—bone cancer	0.000675	0.000712	CcSEcCtD
Quinidine barbiturate—Nausea—Methotrexate—bone cancer	0.000674	0.00071	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Doxorubicin—bone cancer	0.000672	0.000709	CcSEcCtD
Quinidine barbiturate—Rash—Epirubicin—bone cancer	0.00067	0.000706	CcSEcCtD
Quinidine barbiturate—Dermatitis—Epirubicin—bone cancer	0.000669	0.000705	CcSEcCtD
Quinidine barbiturate—Headache—Epirubicin—bone cancer	0.000665	0.000701	CcSEcCtD
Quinidine barbiturate—Dizziness—Doxorubicin—bone cancer	0.00065	0.000685	CcSEcCtD
Quinidine barbiturate—GABRA2—Orphan transporters—TUBB4B—bone cancer	0.000649	0.0218	CbGpPWpGaD
Quinidine barbiturate—Nausea—Epirubicin—bone cancer	0.000631	0.000665	CcSEcCtD
Quinidine barbiturate—Vomiting—Doxorubicin—bone cancer	0.000625	0.000658	CcSEcCtD
Quinidine barbiturate—Rash—Doxorubicin—bone cancer	0.00062	0.000653	CcSEcCtD
Quinidine barbiturate—Dermatitis—Doxorubicin—bone cancer	0.000619	0.000652	CcSEcCtD
Quinidine barbiturate—Headache—Doxorubicin—bone cancer	0.000616	0.000649	CcSEcCtD
Quinidine barbiturate—Nausea—Doxorubicin—bone cancer	0.000584	0.000615	CcSEcCtD
Quinidine barbiturate—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.00056	0.0188	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000557	0.0187	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000553	0.0186	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—bone cancer	0.000545	0.0183	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—bone cancer	0.000507	0.017	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000477	0.016	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000466	0.0156	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000448	0.015	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—EIF2S1—bone cancer	0.000427	0.0144	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000415	0.014	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—KIT—bone cancer	0.0004	0.0134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—GRM1—bone cancer	0.000393	0.0132	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—BRAF—bone cancer	0.00032	0.0108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000305	0.0103	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—SMO—bone cancer	0.000277	0.0093	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—MDM2—bone cancer	0.000268	0.00901	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—GRM4—bone cancer	0.000212	0.00713	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—RGS1—bone cancer	0.000212	0.00713	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000193	0.0065	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000191	0.00641	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00019	0.00638	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000171	0.00573	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000159	0.00534	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000158	0.00532	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000157	0.00527	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000143	0.00479	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000137	0.00459	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—JUN—bone cancer	0.000135	0.00454	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000135	0.00454	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—EGFR—bone cancer	0.000134	0.0045	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000134	0.00449	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GRM4—bone cancer	0.000128	0.00432	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—MDM2—bone cancer	0.00012	0.00402	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000117	0.00392	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—JUN—bone cancer	0.000115	0.00388	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000114	0.00383	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000112	0.00376	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000112	0.00376	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GRM1—bone cancer	0.000111	0.00374	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—BRAF—bone cancer	0.000109	0.00367	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.0001	0.00338	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MET—bone cancer	9.99e-05	0.00336	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—BRAF—bone cancer	9.65e-05	0.00324	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	9.54e-05	0.00321	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MDM2—bone cancer	9.16e-05	0.00308	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	8.56e-05	0.00288	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—BRAF—bone cancer	8.48e-05	0.00285	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	8.41e-05	0.00283	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP2—bone cancer	8.33e-05	0.0028	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP3A4—bone cancer	8.33e-05	0.0028	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	8.21e-05	0.00276	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MDM2—bone cancer	8.09e-05	0.00272	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SMO—bone cancer	7.84e-05	0.00264	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—BRAF—bone cancer	7.69e-05	0.00259	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	7.61e-05	0.00256	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRM4—bone cancer	7.26e-05	0.00244	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RGS1—bone cancer	7.26e-05	0.00244	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	7.18e-05	0.00241	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CDK4—bone cancer	7.13e-05	0.0024	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MET—bone cancer	7.13e-05	0.0024	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTP1—bone cancer	7.12e-05	0.00239	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	7.02e-05	0.00236	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM4—bone cancer	6.59e-05	0.00221	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RGS1—bone cancer	6.59e-05	0.00221	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—BRAF—bone cancer	6.56e-05	0.00221	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MDM2—bone cancer	6.45e-05	0.00217	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRM1—bone cancer	6.29e-05	0.00211	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP9—bone cancer	6.26e-05	0.0021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—JUN—bone cancer	5.96e-05	0.002	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP2—bone cancer	5.94e-05	0.002	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM1—bone cancer	5.71e-05	0.00192	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MDM2—bone cancer	5.5e-05	0.00185	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—bone cancer	5.06e-05	0.0017	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NDUFA12—bone cancer	4.99e-05	0.00168	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	4.86e-05	0.00163	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—bone cancer	4.47e-05	0.0015	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NT5C3A—bone cancer	4.13e-05	0.00139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNA11—bone cancer	4.05e-05	0.00136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SMO—bone cancer	4.03e-05	0.00135	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RGS1—bone cancer	3.89e-05	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM4—bone cancer	3.89e-05	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNA11—bone cancer	3.68e-05	0.00124	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL3—bone cancer	3.68e-05	0.00124	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—bone cancer	3.61e-05	0.00121	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM1—bone cancer	3.37e-05	0.00113	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL3—bone cancer	3.34e-05	0.00112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SMO—bone cancer	2.38e-05	0.000799	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNA11—bone cancer	2.17e-05	0.000731	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ATF1—bone cancer	2.02e-05	0.00068	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL3—bone cancer	1.97e-05	0.000663	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ENO2—bone cancer	1.81e-05	0.000609	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFBR2—bone cancer	1.69e-05	0.000567	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DHFR—bone cancer	1.68e-05	0.000565	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1R—bone cancer	1.59e-05	0.000533	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNA11—bone cancer	1.57e-05	0.000528	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP3A4—bone cancer	1.42e-05	0.000479	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTP1—bone cancer	1.22e-05	0.000409	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KIT—bone cancer	1.15e-05	0.000387	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BRAF—bone cancer	1.08e-05	0.000364	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.05e-05	0.000352	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MDM2—bone cancer	9.06e-06	0.000305	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JUN—bone cancer	7.88e-06	0.000265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—bone cancer	7.66e-06	0.000258	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—bone cancer	6.31e-06	0.000212	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—bone cancer	6.19e-06	0.000208	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—bone cancer	5.2e-06	0.000175	CbGpPWpGaD
